- Pages
- 7
- Published in
- United States of America
Premium
u.s. Fda Accepts for Priority Review The
2024
<Macro 'access_denied_modal'>
<Macro 'unauthorized_modal'>
Add to list
Citation
Pfizer, Inc., 2024. u.s. Fda Accepts for Priority Review The, Pfizer, Inc..
United States of America.
Retrieved from https://coilink.org/20.500.12592/1lrd16h on 15 Nov 2024. COI: 20.500.12592/1lrd16h.
Full-page Screenshot
